Catheter-interventional Treatment of Pulmonary Embolism
NCT ID: NCT05456789
Last Updated: 2025-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2022-06-16
2024-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators aim to assess the effects of a combined interventional local fibrinolysis and catheter-thrombectomy and to compare them with conventional treatment in a cohort of patients with intermediate-high-risk pulmonary embolism.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients
NCT06487052
Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary Evaluation
NCT02066597
Catheter Thrombectomy in Patients With Massive Pulmonary Embolism
NCT00314002
Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE
NCT05172115
Pulmonary Embolism International THrOmbolysis Study-3
NCT04430569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Combined interventional treatment
Combined catheter-based fibrinolysis and thrombectomy plus conventional treatment
combined catheter-thrombectomy and local fibrinolysis
combination of catheter-based thrombectomy with local pulmonary fibrinolysis plus conventional treatment
conventional treatment
Conventional treatment
conventional treatment
conventional treatment of pulmonary embolism
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
combined catheter-thrombectomy and local fibrinolysis
combination of catheter-based thrombectomy with local pulmonary fibrinolysis plus conventional treatment
conventional treatment
conventional treatment of pulmonary embolism
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \>= 18 years
Exclusion Criteria
* contraindications for catheter-based treatment
* known allergy to anticoagulant treatment or fibrinolytics
* pregnancy
* participation in other randomized trials
* patients under legal supervision or guardianship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heart Center Leipzig - University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heart Center Leipzig at University of Leipzig
Leipzig, Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CATCH-PE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.